Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
Background. Bedaquiline is currently a drug of choice in therapy for extensively and multidrug-resistant tuberculosis. It is indicated for children from a 6-year age and young adults as part of a combination chemotherapy, in compliance with the medical council’s (MC) regulation on active extensively...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Russo |
| منشور في: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2022-05-01
|
| سلاسل: | Кубанский научный медицинский вестник |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ksma.elpub.ru/jour/article/view/2764 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|